Kalbe Farma Tbk vs Kedoya Adyaraya Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Kedoya Adyaraya Tbk. trades at Rp1,075 (market cap 976.16B, 2.7K 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 33.8× Kedoya Adyaraya Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 2.7K). Which is the better fit depends on your goals.
| KLBF | RSGK | |
|---|---|---|
Market Cap | 33T | 976.16B |
Volume | 98.44M | 2.7K |
Lot | 984.38K | 27 |
Turnover | 70.64B | 2.84M |
Average Price | 717.58 | 1,050.93 |
Value | 70.64B | 2.84M |
Indicative Equilibrium Price | 720 | 1,050 |
Indicative Equilibrium Volume | 43.62K | 900 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.
Read more on RSGK →